Mankind Pharma
Stay updated with the latest news and articles about Mankind Pharma.
Latest Articles
Investec initiates Buy call on Mankind Pharma, expects 35% upside in stock price
Investec has initiated coverage on Mankind Pharma (MNKI) with a "Buy" rating and a target price of ₹3,300, indicating a 35% upside from the previous close of ₹2,442.
By
Markets Desk
Stocks To Watch Today: Tata Consumer Products, Lupin, Mankind Pharma, SJVN
Top stocks to watch today are Tata Consumer Products, Lupin, Mankind Pharma, SJVN.
By
Markets Desk
Mankind Pharma promoters to offload stake via block deal tomorrow, deal size at Rs 1,330 crore
Business
·
According to sources, the block deal is likely to take place tomorrow and the total size of the block is worth Rs 1,330.4 crore.
By
Markets Desk
Mankind Pharma IPO to open on April 25
Business
·
Mankind Pharma Limited headquartered in Delhi is all set to open its IPO of 40,058,844 Equity Shares on Tuesday, April 25, 2023.
By
Markets Desk
Showing 26 of 26 articles